A rare cause of recurrent nasal polyposis in adolescent age group: Samter’s syndrome

References (11)

1. Stevenson DD, Simon RA. Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol 2006;118:801-4
2. Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 2013;68:1219-32
3. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004;328:434
4. Chen BS, Virant FS, Parikh SR, Manning SC. Aspirin sensitivity syndrome (Samter’s Triad): an unrecognized disorder in children with nasal polyposis. Int J Pediatr Otorhinolaryngol 2013;77:281-3
5. Lee RU, Stevenson DD. Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res 2011;3:3-10
6. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000;16:432-6
7. Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002;89:474-8
8. Scott DR, White AA. Approach to desensitization in aspirinexacerbated respiratory disease. Ann Allergy Asthma Immunol 2014;112:13-7
9. Comert S, Celebioglu E, Yucel T, et al. Aspirin 300 mg/day is effective for treating aspirin-exacerbated respiratory disease. Allergy 2013;68:1443-51
10. Woessner KM, White AA. Evidence-based approach to aspirin desensitization in aspirinexacerbated respiratory disease. J Allergy Clin Immunol 2014;133:286-7.e1-9
11. Ertoy Karagöl Hİ, Yılmaz Ö, Topal E, et al. Aspirinle Desensitize Edilen Adolesan Samter Sendromu Olgusu: Tanı ve Tedavi Yaklaşımı. Turkiye Klinikleri J Pediatr 2015;24:63-7.